Plain-English translation of NCT07776613 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to see if it can help build bone strength in people who have breast cancer that has spread to their bones. Participants in this study will also have osteoporosis (weak bones). Researchers want to learn whether this medication can help prevent fractures and is safe for people in this situation.
When breast cancer spreads to the bones, it can weaken them and increase the risk of fractures. People with this condition often also develop osteoporosis. There's a need for treatments that can both fight bone loss and potentially help rebuild bone strength in this specific group of patients.
You likely qualify if…
You likely don't qualify if…
You will receive injections of the medication at a dose of 210 mg. The trial will monitor how well your bones are responding to the treatment and whether it is safe for you. You will likely have bone density scans and blood tests to measure bone health and calcium levels at different points during the study. The exact schedule of visits and length of the trial will be explained to you when you join.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States